Recombinant Human Small Ubiquitin-Related Modifier 2, GST(Discontinued)
Shipping Info:
For estimated delivery dates, please contact us at [email protected]
| Amount : | 5 µg |
| Content : | SUMO2 at 100µg/ml in 50mM Tris-Acetate, pH7.5, 1mM EDTA and 20% Glycerol. |
| Storage condition : | as opposed to ubiquitin which targets proteins for degradation. SUMO2 is not active until the last two amino acids of the carboxy-terminus have been cleaved off. |
| Alternative Name : | Small ubiquitin-related modifier 2, SUMO-2, Ubiquitin-like protein SMT3B, SMT3 homolog 2, Sentrin-2, HSMT3, SUMO-3, SUMO2, SMT3B, SMT3H2, MGC117191. |
Source : Escherichia Coli.
SUMO2 Human Recombinant full length protein expressed in E.coli, shows a 36 kDa band on SDS-PAGE(including GST tag).The SUMO2 is purified by proprietary chromatographic techniques.
SUMO2 is a member of the SUMO (small ubiquitin-like modifier) protein family. SUMO2 also known as SUMO-3 is a novel ubiquitin-like protein that can be conjugated to other proteins in a manner analogous to ubiquitination. It is a 95 amino acid peptide that is 46% identical and 66% homologous to sentrin-1. Sentrin interacts with the death domains of Fas, TNFR1, PML, Rad51 and Rad52 which are involved in repairing dsDNA breaks, and with GAP1. SUMO2 function is similar to that of ubiquitin by being bound to target proteins as part of a post-translational modification system. SUMO2 is involved in a variety of cellular processes, for example nuclear transport, transcriptional regulation, apoptosis, and protein stability as opposed to ubiquitin which targets proteins for degradation. SUMO2 is not active until the last two amino acids of the carboxy-terminus have been cleaved off.
For Research Use Only. Not for use in diagnostic/therapeutics procedures.
|
There are currently no product reviews
|
.png "ACE2/HEK293 Stable Cell Line")
